Michael Hecht Olsen
About
Michael Hecht Olsen is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Michael Hecht Olsen has authored 266 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 198 papers in Cardiology and Cardiovascular Medicine, 45 papers in Endocrinology, Diabetes and Metabolism and 40 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Hecht Olsen's work include Blood Pressure and Hypertension Studies (117 papers), Cardiovascular Health and Disease Prevention (63 papers) and Cardiovascular Function and Risk Factors (54 papers). Michael Hecht Olsen is often cited by papers focused on Blood Pressure and Hypertension Studies (117 papers), Cardiovascular Health and Disease Prevention (63 papers) and Cardiovascular Function and Risk Factors (54 papers). Michael Hecht Olsen collaborates with scholars based in Denmark, United States and Sweden. Michael Hecht Olsen's co-authors include Kristian Wachtell, Hans Ibsen, Richard B. Devereux, Sverre E. Kjeldsen, Markku S. Nieminen, Lars Lindholm, Tine W. Hansen, Eva Gerdts, Stevo Julius and Thomas Sehestedt and has published in prestigious journals such as The Lancet, JAMA and Circulation.
In The Last Decade
Michael Hecht Olsen
255 papers receiving 7.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Michael Hecht Olsen Denmark | 44 | 5.7k | 1.3k | 970 | 891 | 835 | 266 | 8.0k | ||
| Janice Pogue Canada | 29 | 4.7k 0.8× | 1.4k 1.1× | 960 1.0× | 635 0.7× | 999 1.2× | 43 | 7.8k | ||
| Laura R. Loehr United States | 45 | 4.5k 0.8× | 697 0.5× | 698 0.7× | 906 1.0× | 601 0.7× | 146 | 7.1k | ||
| Inger Njølstad Norway | 52 | 3.5k 0.6× | 1.3k 1.0× | 1.3k 1.3× | 1.2k 1.3× | 713 0.9× | 214 | 9.8k | ||
| Kenneth Dickstein Norway | 47 | 8.7k 1.5× | 1.1k 0.9× | 1.1k 1.1× | 1.3k 1.5× | 916 1.1× | 166 | 11.9k | ||
| Shih‐Jen Hwang United States | 38 | 3.1k 0.5× | 1.1k 0.8× | 871 0.9× | 699 0.8× | 995 1.2× | 102 | 6.4k | ||
| Eric Leip United States | 36 | 9.9k 1.7× | 1.5k 1.1× | 1.3k 1.3× | 1.1k 1.2× | 490 0.6× | 117 | 14.6k | ||
| Jan Skov Jensen Denmark | 43 | 5.1k 0.9× | 1.6k 1.2× | 1.3k 1.3× | 783 0.9× | 1.4k 1.7× | 188 | 8.1k | ||
| Graham S. Hillis Australia | 45 | 5.2k 0.9× | 827 0.6× | 1.7k 1.8× | 729 0.8× | 538 0.6× | 195 | 8.6k | ||
| Mátyás Keltai Hungary | 30 | 5.3k 0.9× | 1.5k 1.1× | 1.8k 1.8× | 411 0.5× | 546 0.7× | 71 | 7.0k | ||
| Peter Bramlage Germany | 44 | 4.1k 0.7× | 2.1k 1.6× | 1.7k 1.7× | 908 1.0× | 347 0.4× | 464 | 7.7k |
Countries citing papers authored by Michael Hecht Olsen
Since
Specialization
Citations
This map shows the geographic impact of Michael Hecht Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hecht Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hecht Olsen more than expected).
Fields of papers citing papers by Michael Hecht Olsen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Michael Hecht Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hecht Olsen. The network helps show where Michael Hecht Olsen may publish in the future.
Co-authorship network of co-authors of Michael Hecht Olsen
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hecht Olsen. A scholar is included among the top collaborators of Michael Hecht Olsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hecht Olsen. Michael Hecht Olsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lund, A K, Roderick C. Jones, Michael Hecht Olsen, et al.. (2025). Improving Universal Suicide Risk Screening Rates at a Children’s Hospital. PEDIATRICS. 155(5).
2.
Andersen, Mette K., Charlotte Brøns, Torben Hansen, et al.. (2025). Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 27(4). 2002–2011.
3.
Arend, Britt W. H. van der, et al.. (2024). Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine. Frontiers in Neurology. 15. 1387044–1387044.
4.
Olesen, Thomas Bastholm, et al.. (2024). The Impact of Education Level on Weight Loss in a Primary Care-Anchored eHealth Lifestyle Coaching Program in Denmark: A Randomized Controlled Trial. Nutrients. 16(6). 795–795.
5.
Greve, Anders M., Ahmad Sajadieh, Michael Hecht Olsen, et al.. (2024). Development and validation of the Aortic valve Stenosis Guarded by Amplified Risk Determination (ASGARD) risk score for safe monitoring in asymptomatic non-severe aortic valve stenosis. European Journal of Preventive Cardiology. 32(17). 1793–1803.
6.
Gram-Kampmann, Eva-Marie, Thomas Bastholm Olesen, Camilla Dalby Hansen, et al.. (2023). A six-month low-carbohydrate diet high in fat does not adversely affect endothelial function or markers of low-grade inflammation in patients with type 2 diabetes: an open-label randomized controlled trial. Cardiovascular Diabetology. 22(1). 212–212.
7.
Greve, Anders M., Ahmad Sajadieh, Michael Hecht Olsen, et al.. (2023). Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial. EClinicalMedicine. 58. 101875–101875.
8.
Sharman, James E., Andrew Searles, Aletta E. Schutte, et al.. (2023). Improving the accuracy of blood pressure measuring devices in Australia: a modelled return on investment study. Journal of Human Hypertension. 38(2). 177–186.
9.
Sharman, James E., Pedro Ordúñez, Tammy M. Brady, et al.. (2022). The urgency to regulate validation of automated blood pressure measuring devices: a policy statement and call to action from the world hypertension league. Journal of Human Hypertension. 37(2). 155–159.
10.
Giraldo, Gloria, Kristy Joseph, Sonia Y. Angell, et al.. (2021). Mapping stages, barriers and facilitators to the implementation of HEARTS in the Americas initiative in 12 countries: A qualitative study. Journal of Clinical Hypertension. 23(4). 755–765.
11.
Feinberg, Joshua, Michael Hecht Olsen, Axel Brandes, et al.. (2021). Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trial. BMJ Open. 11(3). e044744–e044744.
12.
Olsen, Michael Hecht, et al.. (2020). Factors affecting the fruit and vegetable intake in Nepal and its association with history of self-reported major cardiovascular events. BMC Cardiovascular Disorders. 20(1). 425–425.
13.
Gram-Kampmann, Eva-Marie, et al.. (2020). Changes in Retinal Microvasculature Parameters after Low-Carbohydrate, High-Fat Diet in Type 2 Diabetes: A Randomized-Controlled Trial of Danish Type 2 Diabetic Patients. European Journal of Ophthalmology. 30.
14.
Kristensen, Anna Meta Dyrvig, Muthiah Vaduganathan, Deepak L. Bhatt, et al.. (2020). Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography. Journal of Clinical Hypertension. 22(9). 1647–1658.
15.
Byrne, Christina, Manan Pareek, Muthiah Vaduganathan, et al.. (2019). Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial. European Heart Journal - Cardiovascular Pharmacotherapy. 6(6). 356–363.
16.
Pareek, Manan, et al.. (2018). Nye antidiabetiske lægemidler og kardiovaskulære komplikationer. Ugeskrift for Læger. 180(11). 2–6.
17.
Haugaard, Steen B., Ove Andersen, Tine W. Hansen, et al.. (2011). The immune marker soluble urokinase plasminogen activator receptor is associated with new‐onset diabetes in non‐smoking women and men. Diabetic Medicine. 29(4). 479–487.
18.
Bang, Lia E., Niels Wiinberg, Kristian Wachtell, et al.. (2007). Losartan versus atenolol on 24‐hour ambulatory blood pressure. A LIFE substudy. Blood Pressure. 16(6). 392–397.
19.
Hildebrandt, Per, Mikael Boesen, Michael Hecht Olsen, Kristian Wachtell, & Bjoern A. Groenning. (2004). N-Terminal Pro Brain Natriuretic Peptide in Arterial Hypertension—A Marker for Left Ventricular Dimensions and Prognosis. European Journal of Heart Failure. 6(3). 313–317.
20.
Olsen, Michael Hecht, Kristian Wachtell, Jonathan N. Bella, et al.. (2002). Left Ventricular Hypertrophy is Associated with Reduced Vasodilatory Capacity in the Brachial Artery in Patients with Longstanding Hypertension. A LIFE Substudy. Blood Pressure. 11(5). 285–292.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Janice Pogue Breakdown of academic impact, for papers by Laura R. Loehr Breakdown of academic impact, for papers by Inger Njølstad Breakdown of academic impact, for papers by Kenneth Dickstein Breakdown of academic impact, for papers by Shih‐Jen Hwang Breakdown of academic impact, for papers by Eric Leip Breakdown of academic impact, for papers by Jan Skov Jensen Breakdown of academic impact, for papers by Graham S. Hillis Breakdown of academic impact, for papers by Mátyás Keltai Breakdown of academic impact, for papers by Peter Bramlage